These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

424 related articles for article (PubMed ID: 2821108)

  • 41. Two different molecular pathways account for low IL-2 receptor and c-myc mRNA expression by lpr Lyt-2- L3T4- T cells.
    Katagiri K; Katagiri T; Yokota S; Eisenberg RA; Cohen PL; Ting JP
    J Immunol; 1988 Sep; 141(6):2145-52. PubMed ID: 3139753
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Activation of murine CD8+ lymphocytes: two distinct signals regulate c-myc and interleukin 2 receptor RNA expression.
    Hardt C
    Eur J Immunol; 1987 Dec; 17(12):1711-7. PubMed ID: 3121357
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Uncoupling of c-myc mRNA expression from G1 events in human T lymphocytes.
    Friedrich B; Gullberg M; Lundgren E
    Anticancer Res; 1988; 8(1):23-8. PubMed ID: 3128958
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Kinetics of cellular oncogene expression in mouse lymphocytes. II. Regulation of c-fos and c-myc gene expression.
    Schneider-Schaulies J; Schimpl A; Wecker E
    Eur J Immunol; 1987 May; 17(5):713-8. PubMed ID: 3556196
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cognate T cell help for CD40-deficient B cells induces c-myc RNA expression, but DNA synthesis requires an additional signal through surface Ig.
    Schrader CE; Stavnezer J; Kikutani H; Parker DC
    J Immunol; 1997 Jan; 158(1):153-62. PubMed ID: 8977186
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Up-regulation of c-fos expression is a component of the mIg signal transduction mechanism but is not indicative of competence for proliferation.
    Monroe JG
    J Immunol; 1988 Mar; 140(5):1454-60. PubMed ID: 3126226
    [TBL] [Abstract][Full Text] [Related]  

  • 47. IL-12-induced activation of NK and T cells occurs in the absence of immediate-early activation gene expression.
    Azzoni L; Kanakaraj P; Zatsepina O; Perussia B
    J Immunol; 1996 Oct; 157(8):3235-41. PubMed ID: 8871617
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Valency of CD3 binding and internalization of the CD3 cell-surface complex control T cell responses to second signals: distinction between effects on protein kinase C, cytoplasmic free calcium, and proliferation.
    Ledbetter JA; June CH; Martin PJ; Spooner CE; Hansen JA; Meier KE
    J Immunol; 1986 Jun; 136(11):3945-52. PubMed ID: 3084650
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Transcriptional down-regulation of c-myc expression by protein synthesis-dependent and -independent pathways in a human T lymphoblastic tumor cell line.
    Bading H; Moelling K
    Cell Growth Differ; 1990 Mar; 1(3):113-7. PubMed ID: 2127692
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cyclic AMP-mediated suppression of normal and neoplastic B cell proliferation is associated with regulation of myc and Ha-ras protooncogenes.
    Blomhoff HK; Smeland EB; Beiske K; Blomhoff R; Ruud E; Bjøro T; Pfeifer-Ohlsson S; Watt R; Funderud S; Godal T
    J Cell Physiol; 1987 Jun; 131(3):426-33. PubMed ID: 3036888
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Oncogenes with potential nuclear function: myc, myb and fos.
    Eisenman RN; Thompson CB
    Cancer Surv; 1986; 5(2):309-27. PubMed ID: 3779660
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Regulation of cell cycle entry and G1 progression by CSF-1.
    Roussel MF
    Mol Reprod Dev; 1997 Jan; 46(1):11-8. PubMed ID: 8981358
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Modulation of c-myc, c-myb, c-fos, c-sis and c-fms proto-oncogene expression and of CSF-1 transcripts and protein by phorbol diester in human malignant histiocytosis DEL cell line with 5q 35 break point.
    Gogusev J; Barbey S; Nezelof C
    Anticancer Res; 1993; 13(4):1043-7. PubMed ID: 8352523
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Changes in gene expression associated with IFN-beta and IL-2-induced augmentation of human natural killer cell function.
    Kornbluth J; Hoover RG
    J Immunol; 1988 Nov; 141(9):3234-40. PubMed ID: 3049820
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Quantitative and qualitative signals determine T-cell cycle entry and progression.
    Modiano JF; Mayor J; Ball C; Chitko-McKown CG; Sakata N; Domenico-Hahn J; Lucas JJ; Gelfand EW
    Cell Immunol; 1999 Oct; 197(1):19-29. PubMed ID: 10555992
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Proliferating cell nuclear antigen (PCNA)/cyclin in activated human T lymphocytes.
    Kurki P; Lotz M; Ogata K; Tan EM
    J Immunol; 1987 Jun; 138(12):4114-20. PubMed ID: 2884260
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Transformation of T lymphocytes by the v-fos oncogene.
    Valge-Archer VE; de Villiers J; Sinskey AJ; Rao A
    J Immunol; 1990 Dec; 145(12):4355-64. PubMed ID: 2124241
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Regulation of nuclear factor-kappa B and activator protein-1 activities after stimulation of T cells via glycosylphosphatidylinositol-anchored Ly-6A/E.
    Ivanov V; Fleming TJ; Malek TR
    J Immunol; 1994 Sep; 153(6):2394-406. PubMed ID: 7915738
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Autocrine regulation of T-lymphocyte proliferation: differential induction of IL-2 and IL-2 receptor.
    Cantrell DA; Collins MK; Crumpton MJ
    Immunology; 1988 Nov; 65(3):343-9. PubMed ID: 3264805
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effects of interferon-gamma on proto-oncogene expression during induction of human monocytic differentiation.
    Sariban E; Mitchell T; Griffin J; Kufe DW
    J Immunol; 1987 Mar; 138(6):1954-8. PubMed ID: 3102606
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.